Pleural mesothelioma incidence in Europe: Evidence of some deceleration in the increasing trends

Cancer Causes and Control

Volumn 14, Issue 8, 2003, Pages 791-803

  Montanaro, Fabio ^a,d   Bray, Freddie ^b   Gennaro, Valerio ^a   Merler, Enzo ^c   Tyczynski, Jerzy E ^b   Parkin, Donald Maxwell ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c Occupational Health Unit   (Italy)

^d INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Asbestos exposure; Cancer registration; Incidence rates; Pleural mesothelioma; Time trends

Indexed keywords

ASBESTOS;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DECELERATION; DENMARK; ENVIRONMENTAL EXPOSURE; ESTONIA; EUROPE; EVIDENCE BASED MEDICINE; EXTRACTION; FEMALE; FRANCE; GENDER; GEOGRAPHY; HEALTH CARE MANAGEMENT; HEALTH SURVEY; HUMAN; MALE; MODEL; NETHERLANDS; PLEURA MESOTHELIOMA; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; SPAIN; UNITED KINGDOM; YUGOSLAVIA (PRE-1992);

ASBESTOS; ENVIRONMENTAL EXPOSURE; EUROPE; FORECASTING; HUMANS; INCIDENCE; LINEAR MODELS; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; RISK FACTORS;

EID: 0242640655     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026300619747     Document Type: Article

References (58)

1. McDonald JC, McDonald AD (1996) The epidemiology of mesothelioma in historical context. Eur Resp J 9: 1932-1942.
2. McDonald JC (1985) Health implications of environmental exposure to asbestos. Environ Health Perspect 62: 319-328.
3. Gennaro V, Finkelstein MM, Ceppi M, et al. (2000) Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am J Ind Med 37: 275-282.
4. Ross D, McDonald JC (1995) Occupational and geographical factors in the epidemiology of malignant mesothelioma. Monaldi Arch Chest Dis 50: 459-463.
5. Ascoli V, Calisti R, Carnovale-Scalzo C, Nardi F (2001) Malignant pleural mesothelioma in bakers and pastry cooks. Am J Ind Med 40: 371-373.
6. Gennaro V, Ceppi M, Boffetta P, Fontana V, Perrotta A (1994) Pleural mesothelioma and asbestos exposure among Italian oil refinery workers. Scand J Work Environ Health 20: 213-215.
7. Carbone M, Rizzo P, Pass HI (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15: 1877-1888.
8. Carbone M, Rizzo P, Pass H (2000) Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res 20: 875-878.
9. Selikoff U, Hammond EC, Seidmann H (1980) Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46: 2736-2740.
10. Andersson M, Olsen JH (1985) Trend and distribution of mesothelioma in Denmark. Br J Cancer 51: 699-705.
11. Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H (1997) Trends in mesothelioma incidence and occupational mesotheliomas in Finland 1960-1995. Scand J Work Environ Med 23: 266-270.
12. Jarvholm B, Englund A, Albin M (1999) Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 56: 110-113.
13. Janssen-Heijnen MLG, Damhuis RAM, Klinkhamer PJJM, Schipper RM, Coebergh J-WW (1999) Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population based study. Eur J Cancer Prev 8: 311-314.
14. Gennaro V, Montanaro F, Lazzarotto A, Bianchelli M, Celesia MV (2000) Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area. Epid Prev 24: 213-218.
15. Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345: 535-539.
16. Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79: 666-672.
17. La Vecchia C, Decarli A, Peto J, Levi F, Tomei F, Negri E (2000) An age, period and cohort analysis of pleural cancer mortality in Europe. Eur J Cancer Prev 9: 179-184.
18. Gilg Soit Ilg A, Bignon J, Valleron A-J (1998) Estimation of past and future burden of mortality from mesothelioma in France. Occup Environ Med 55: 760-765.
19. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S (2000) Future trends in mortality of French men form mesothelioma. Occup Environ Med 57: 188-494.
20. Merler E, Lagazio C, Biggeri A (1999) Trends in mortality from primary pleural tumors and incidence of pleural mesothelioma in Italy: a very serious situation. Epid Prev 23: 316-326.
21. European Network of Cancer Registries (2001) Eurocim version 4.0. European incidence database V2.3, 730-entity dictionary, Lyon.
22. International Agency for Research on Cancer (1997) Cancer Incidence in Five Continents. Vol VII. Lyon: IARC Sci Publ.
23. Archivio Regionale Toscano dei Mesoteliomi Maligni: Rapporto sulla casistica 1988-2000. Centro Stampa, Gunta Regionale, Firenze 2002.
24. Boyle P, Parkin DM (1991) Statistical methods for registries. In: Cancer Registration: Principles and Methods Vol. 95. Lyon: IARC Sci Publ., 95: 126-158.
25. StataCorp. (2003) Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation Tests for Joinpoint Regression with Applications to Cancer Rates. Stat Med 19: 335-351.
27. Albin M, Magnani C, Krstev S, Rapiti E, Shefer I (1999) Asbestos and cancer: an overview of current trends in Europe. Environ Health Perspect 107(Suppl 2): 289-298.
28. Wagner JC, Sleggs CA, Merchand P (1960) Diffuse pleural mesothelioma in the Northwestern Cape Province. Br J Ind Med 17: 260-271.
29. Hodgson JT, Darnton A (2000) The quantative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44: 565-601.
30. Smith AH, Wright CC (1996) Chrystolite asbestos is the main cause of pleural mesothelioma. Am J Indl Med 30: 252-266.
31. Meurman LO, Pukkala E, Hakama M (1994) Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med 51(6):421-425.
32. Roggli VL, Vollmer RT, Butnor KJ, Sporn TA (2002) Tremolite and mesothelioma. Ann Occup Hyg 46: 447-453.
33. Roggli VL, Sanfilippo F, Shelburne JD (1992) Mesothelioma. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of Asbestos-Associated Diseases. Boston, MA: Little, Brown & Co., Ch. 5, pp. 109-165.
34. Huncharek M (2002) Non-asbestos related diffuse malignant mesothelioma. Tumori 88: 1-9.
35. Huncharek M (1995) Genetic factors in the aetiology of malignant mesothelioma. Eur J Cancer 31A: 1741-1747.
36. Bolognesi C, Filiberti R, Neri M, et al. (2002) High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma. Cancer Res 62: 5418-5419.
37. Klein G, Powers A, Croce C (2002) Association of SV40 with human tumors. Oncogene 21: 1141-1149.
38. Strickler HD, Goedert JJ, Flemming M, et al. (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 5: 473-475.
39. Mulatero C, Surentheran T, Breuer J, Rudd RM (1999) Simian virus 40 and human pleural mesothelioma. Thorax 54: 60-61.
40. Emri S, Kocagoz T, Olut A, et al. (2000) Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 20: 891-894.
41. Hübner R, Van Marck E (2002) Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Causes Control 13: 121-129.
42. Hirvonen A, Mattson K, Karjalainen A, et al. (1999) Simian virus S40 (sv40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminted polio vaccines. Mol Carcinog 26(2): 93-99.
43. Cerrano PG, Jasani B, Filiberti R, et al. (2003) Simian virus 40 and malignant mesothelioma (Review). Int J Oncol 22(1): 187-194.
44. Tweedaleg. Magic Mineral to Killer Dust: Turner & Newall and the Asbestos Hazard. Oxford University Press, 2000.
45. Kazan-Allen L (2002) National asbestos bans. In: http:// www.ibas.btinternet.co.uk/index.htm.
46. Bianchi C, Giarelli L, Grandi G, Brollo A, Ramani L, Zuch C (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6: 162-166.
47. Damhuis RAM (2000) Trend in incidence of and mortality from mesothelioma. In: Damhuis RAM, van Dijck JAAM, Siesling S, Janssen-Heijnen MLG, eds. Lung Cancer and Mesothelioma in the Netherlands 1989-1997. Utrecht: The Netherlands Cancer Registry, pp. 12-13.
48. Spirtas R, Beebe GW, Connelly RR, et al. (1986) Recent trends in mesothelioma incidence in the United States. Am J Ind Med 9: 397-407.
49. Price B (1997) Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145: 211-218.
50. Kjellstrom T, Smartt P (2000) Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started. New Zealand Med J 113: 485-489.
51. Leigh J, Davidson P, Hendrie L, Berry D (2002) Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 41: 188-201.
52. Gorini G, Merler E, Chellini E, Crocetti E, Costantini AS (2002) Is the ratio of pleural mesothelioma mortality to pleural cancer mortality approximately unity for Italy? Considerations from the oldest regional mesothelioma register in Italy. Br J Cancer 86: 1970-1971.
53. Bruno C, Comba P, Maiozzi P, Vetrugno T (1996) Accuracy of death certification of pleural mesothelioma in Italy. Eur J Epidemiol 12: 421-423.
54. Giarelli L, Grandi G, Bianchi C (1997) Malignant mesothelioma of the pleura in the Trieste-Monfalcone area, with particular regard to shipyard workers. Med Lav 88(4): 316-320.
55. Puntoni R, Vercelli M, Merlo F, Valerio F, Santi L (1979) Mortality among shipyard workers in Genoa, Italy. Ann NY Acad Sci 330: 353-377.
56. Puntoni R, Merlo F, Borsa L, Reggiardo G, Garrone E, Ceppi M (2001) A historical cohort mortality study among shipyard workers in Genova, Italy. Am J Ind Med 40: 363-370.
57. Damhuis RAM, van Gelder T (1993) Malignant mesothelioma in the Rotterdam area, 1987-1989. Eur J Cancer 29A(10): 1478-1479.
58. Scottish Cancer Intelligence Unit (2002) Mesothelioma - key facts. Scottish Cancer Therapy Network Newslett 34: 5.